0 – Page 2 of 2 – Cambridge Enterprise

University of Cambridge

Portfolio company Mission Therapeutics awarded research grant from the Michael J Fox Foundation

Storm Therapeutics announces appointment of CEO and Chairman

24 February 2017

An update from Apollo Therapeutics

22 February 2017

£14m funding round for spinout ApcinteX

02 February 2017

University spin-out Cambridge Graphene acquired by Versarien

20 January 2017

Cambridge and Kew join forces to find new antimicrobial substances in plants

16 January 2017

Cambridge Enterprise joins £2.4 million funding for Cytora

13 January 2017